In the present study, we found that SULF2 acts as an oncogenic protein in prostate cancer cells once cells overexpressing SULF2 presented increased cell viability and migration, which has already been observed in different tumor cells previous studied, where the overexpression of SULF2 had also been performed [25,31,32]. The gene discussed is SULF2; the disease is prostate carcinoma.